Calibration results revealed a consistent alignment between anticipated and observed outcomes, especially notable at the 1- and 3-year marks, underscoring LIPT1’s substantial prognostic significance in NSCLC (Figure 3D). The gene discussed is LIPT1; the disease is non-small cell lung carcinoma.